| 000 | 01781 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515060731.0 | ||
| 264 | 0 | _c20071025 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s00280-007-0419-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPentheroudakis, G | |
| 245 | 0 | 0 |
_aWeekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cOct 2007 |
||
| 300 |
_a733-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 700 | 1 | _aPappas, P | |
| 700 | 1 | _aGolfinopoulos, V | |
| 700 | 1 | _aFountzilas, G | |
| 700 | 1 | _aNikolaidou, M | |
| 700 | 1 | _aBoumba, V A | |
| 700 | 1 | _aVougiouklakis, T | |
| 700 | 1 | _aNikiforidis, L | |
| 700 | 1 | _aTzamakou, E | |
| 700 | 1 | _aSiarabi, O | |
| 700 | 1 | _aMarselos, M | |
| 700 | 1 | _aPavlidis, N | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 60 _gno. 5 _gp. 733-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-007-0419-6 _zAvailable from publisher's website |
| 999 |
_c16890439 _d16890439 |
||